
Accession Therapeutics
Accession Therapeutics is a biotech company in Oxford, United Kingdom, founded in 2021. It has raised $40.0M across 1 round, most recently a $40.0M Venture Round in December 2025.
Immuno-oncology
- Headquarters
- Oxford
- Employees
- 11–50
- Founded
- 2021
- Website
- accessiontherapeutics.com
- Total Funding
- $40.0M
- Last Round
- $40.0M Venture RoundDec 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Accession Therapeutics develops targeted immuno-oncology treatments using its stealth virus platform, Trocept, to address cancer. Its proprietary pipeline combines highly targeted products with a range of therapeutic payloads. Its first drug candidate is in Phase 1 and recruiting patients in the ATTEST trial, with additional engineered candidates following in development.
Summary
It lists 11–50 employees. It has raised $40.0M in total across 1 round, most recently a $40.0M Venture Round in Dec 2025.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/accession-therapeutics"><img src="https://indexed.vc/api/badge/company/accession-therapeutics" alt="Accession Therapeutics on Indexed.vc" width="260" height="76" /></a>